THE USE OF INTERLEUKIN INHIBITORS IN CHRONIC HEADACHES

dc.contributor.authorAkhmedova Dilafruz Bahodirovna
dc.date.accessioned2025-12-29T14:43:53Z
dc.date.issued2024-10-31
dc.description.abstractMigraine is a chronic disease that accounts for 15% worldwide. It is one of the most important causes of disability among women under 50 years of age. Migraines cause difficulties in socio-economic and everyday life. Chronic migraine causes a sharp decrease in the quality of life of the patient, leading to an increase in the cost of the disease, both directly and indirectly. In order to prevent migraine-related disability, today there are ways to prevent disease attacks and prevent seizures. Chronic migraines usually occur after episodic migraines. This has been confirmed in a large number of studies. Immunological mechanisms in migraines are studied as far as hanuz
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/3/article/view/2027
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/22539
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/3/article/view/2027/2012
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Discoveries: Journal of Analysis and Inventions; Vol. 2 No. 10 (2024): WOD; 69-71
dc.source2938-3773
dc.subjectmigraine, tension headache, chronic headache, comorbid disorder.
dc.titleTHE USE OF INTERLEUKIN INHIBITORS IN CHRONIC HEADACHES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
bahodirovna_2024_the_use_of_interleukin_inhibitors_in_chr.pdf
item.page.filesection.size
213.73 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections